Alendronate increased bone mineral density but did not reduce new fractures in glucocorticoid induced osteoporosis.
Compston
J E
JE
Department of Medicine, Box 157, Level 5, Addenbrooke's Hospital, Hills. Road, Cambridge CB2 2QQ, UK.
D019386:Alendronate / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects; D012968:Etidronic Acid / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced* / Q000188:drug therapy; D011239:Prednisolone / Q000009:adverse effects*
D005938:Glucocorticoids; D011239:Prednisolone; D012968:Etidronic Acid; D019386:Alendronate